Pantoprazole Sodium for Injection — Class III drug recall D-0470-2017
Terminated recall by Aurobindo Pharma USA Inc, reported 2017-02-15, distributed nationwide. Discoloration: Some vials were found to contain powder with a yellowish-brownish appearance.
| Recall number | D-0470-2017 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Aurobindo Pharma USA Inc, Plainsboro, NJ, United States |
| Recall initiated | 2016-12-16 |
| Classified | 2017-02-08 |
| Reported by FDA | 2017-02-15 |
| Terminated | 2020-07-29 |
| Distributed | Nationwide (US) |
| Quantity | 29,800 vials |
| NDC | 55150-0202, 55150-0202-00, 55150-0202-10, 55150-0202-25 |
| Lot numbers | CPO160028 |
| Expiration dates | 2018-06-20 |
Product
Pantoprazole Sodium for Injection, 40mg per vial, Single-dose vial, Rx only, Mfd. in India for: Auromedics Pharma LLC 6 Wheeling Road, Dayton, NJ 08810, NDC 55150-202-00
Reason for recall
Discoloration: Some vials were found to contain powder with a yellowish-brownish appearance.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0470-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.